BASEL, Switzerland, July 20 -- The Journal of Cancer Research and Clinical Oncology, a peer-reviewed journal from the German Cancer Society that says it covers carcinogenesis, molecular biology, diagnostic and experimental pathology, published research articles on the following topics in its Vol. 149, No. 9 edition:

Research:

* Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas